SCHEMBL18926558

SCHEMBL18926558

Cc1ccc(S(=O)(=O)OCCCc2cccc(S(=O)(=O)c3ccc(C)cc3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.48
GAA P10253 1/20 0.43
HTT P42858 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CYP24A1 Q07973 2/20 0.42
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
CYP19A1 P11511 1/20 0.40
PSMD10 O75832 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SFRP1 Q8N474 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
FKBP1A P62942 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18934283 0.92 CYP19A1 (0.48) L3MBTL1CYP24A1BCHEACHECYP19A1
SCHEMBL18926560 0.87 GAA (0.50) GAAHTTBCHEACHEPSMD10
SCHEMBL18926556 0.86 CNR2 (0.48) CYP24A1BCHEACHECYP19A1PSMD10
SCHEMBL28710589 0.86 CYP24A1 (0.42) HTTTDP1L3MBTL1CYP24A1CYP19A1
SCHEMBL8098377 0.85 EGFR (0.49) CYP24A1CYP19A1PSMD10CA12CA1
SCHEMBL8780822 0.85 ALDH1A1 (0.44) CYP24A1CYP19A1PSMD10ALDH1A1FKBP1A
SCHEMBL11207479 0.85 LMNA (0.44) TDP1CYP19A1PSMD10SMN1; SMN2ALDH1A1
SCHEMBL7028389 0.84 CNR2 (0.50) L3MBTL1CYP24A1BCHEACHEPSMD10
SCHEMBL10836094 0.84 CHRM2 (0.50) L3MBTL1CYP24A1CA1CA9FKBP1A
SCHEMBL6961246 0.83 CNR2 (0.41) CYP24A1BCHEACHECYP19A1PSMD10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170158521-A1 EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2017-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170158521-A1 EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE CD14, ERG28, DAP3 HTR6 3996/4885GAA 3364/4885HTT 3747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.